2023 Microbiome Market Trends Report 2023: Market is Successfully Commercializing Seres Therapeutics' SER-109 and Rebiotix's RBX-2660 for Recurrent Clostridium Difficile Infection

/PRNewswire/ -- The "2023 Microbiome Market Trend" report has been added to ResearchAndMarkets.com's offering. The microbiome therapeutics market is...

Related Keywords

United States ,Germany ,France ,Canada ,Dublin ,Ireland ,United Kingdom ,Yakult Honsha ,Laura Wood ,Evelo Biosciences ,Technology Platform Overview ,Encapsulation Technology ,Nestle ,Office Hours Call ,Dupont ,E St Office Hours Call ,Major Probiotic Companies ,Seres Therapeutic ,Topics Covered ,Microbial Transplantation ,Free Call ,Hours Call ,Research And Markets ,